CLINICAL TRIALS PROFILE FOR ZAVESCA
✉ Email this page to a colleague
All Clinical Trials for Zavesca
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00319046 ↗ | Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease | Completed | Actelion | Phase 3 | 2006-02-01 | Although miglustat has been approved as a treatment for mild to moderate type 1 Gaucher disease in patients who are unsuitable for enzyme replacement therapy (ERT), more data are required to establish the long term efficacy, safety and tolerability of miglustat in maintaining diseases stability after a switch from ERT. |
NCT00418847 ↗ | Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis | Completed | Actelion | Phase 2 | 2004-07-01 | The purpose of the study is to investigate the pharmacokinetics of Zavesca (miglustat, OGT918) when given as single and multiple doses in juvenile patients with GM2 gangliosidosis. |
NCT00418847 ↗ | Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis | Completed | The Hospital for Sick Children | Phase 2 | 2004-07-01 | The purpose of the study is to investigate the pharmacokinetics of Zavesca (miglustat, OGT918) when given as single and multiple doses in juvenile patients with GM2 gangliosidosis. |
NCT00517153 ↗ | Miglustat in Niemann-Pick Type C Disease | Completed | Actelion | Phase 2 | 2002-01-01 | This is a phase II randomized controlled study of miglustat in adult and juvenile patients with Niemann-Pick Type C disease. Up to 42 patients will be randomised in a 2:1 ratio to either treatment with miglustat or to a non-treatment group. Both groups will follow an identical visit schedule. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Zavesca
Condition Name
Clinical Trial Locations for Zavesca
Trials by Country
Clinical Trial Progress for Zavesca
Clinical Trial Phase
Clinical Trial Sponsors for Zavesca
Sponsor Name